Our roots are in one of America’s great entrepreneurial success stories. Fidelity Investments was founded in 1946 and grew from a single mutual fund into one of the largest asset management firms in the world, with over $2 trillion in assets under management. For the last forty years, our venture capital group has had the privilege of backing other great entrepreneurs as they built ground-breaking companies in technology and life sciences, including Atari, MCI, ROLM Corp., Alibaba, Ironwood Pharmaceuticals, and Ultragenyx.

    Today our funds are larger and more global, but our teams are still small and local. We stay true to our entrepreneurial roots. In the US and Europe, we are F-Prime Capital investing in healthcare (formerly Fidelity Biosciences) and in technology (formerly part of Devonshire Investors). In other geographies, our sister fund is called Eight Roads (formerly Fidelity Growth Partners), with investment teams in London, Shanghai, Beijing, Hong Kong, Tokyo, and Mumbai. Together we bring a world of insight, domain expertise and relationships to support our entrepreneurs. Without the pressure of fundraising from outside investors, we focus all of our time finding and helping great entrepreneurs build important companies.


    We are a group of entrepreneurs, operators, doctors, scientists, and investors. We have low egos, but big vision. We love the same science and technology that you do, and we are passionate when we meet teams with a unique insight on a market or who have found signal buried in data. We believe in the power of entrepreneurs to change the world, yet know that breakthrough medicine and genuine technology innovation take time to develop. We strive to partner with entrepreneurs who embrace that challenge and want an investor who shares their vision and desire to build great companies.


    We feel it’s a privilege both to invest other people’s money and to partner with entrepreneurs. When we meet great teams, we are inspired by the opportunity to help them build their companies. Sometimes we make a big difference, sometimes a small difference; but we always look for teams for whom we have a critical insight and an ability to make a difference at key moments.

    In healthcare, we focus on Biopharmaceuticals, MedTech, and Healthcare IT/Services in a stage-agnostic fashion.  We are constantly searching for the next big thing in healthcare, and sometimes, we will found that something ourselves.

    In technology, we focus on Enterprise IT and FinTech, with a strong enterprise focus in both. We’re an early-stage investor by choice, but will back exceptional teams at any stage.